Literature DB >> 15732097

Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.

Rong Li1, Anne B Johnson, Gajja Salomons, James E Goldman, Sakkubai Naidu, Roy Quinlan, Bruce Cree, Stephanie Z Ruyle, Brenda Banwell, Marc D'Hooghe, Joseph R Siebert, Cristin M Rolf, Helen Cox, Alyssa Reddy, Luis González Gutiérrez-Solana, Amanda Collins, Roy O Weller, Albee Messing, Marjo S van der Knaap, Michael Brenner.   

Abstract

Alexander disease is a progressive, usually fatal neurological disorder defined by the widespread and abundant presence in astrocytes of protein aggregates called Rosenthal fibers. The disease most often occurs in infants younger than 2 years and has been labeled a leukodystrophy because of an accompanying severe myelin deficit in the frontal lobes. Later onset forms have also been recognized based on the presence of abundant Rosenthal fibers. In these cases, clinical signs and pathology can be quite different from the infantile form, raising the question whether they share the same underlying cause. Recently, we and others have found pathogenic, de novo missense mutations in the glial fibrillary acidic protein gene in most infantile patients examined and in a few later onset patients. To obtain further information about the role of glial fibrillary acidic protein mutations in Alexander disease, we analyzed 41 new patients and another 3 previously described clinically, including 18 later onset patients. Our results show that dominant missense glial fibrillary acidic protein mutations account for nearly all forms of this disorder. They also significantly expand the catalog of responsible mutations, verify the value of magnetic resonance imaging diagnosis, indicate an unexpected male predominance for the juvenile form, and provide insights into phenotype-genotype relations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15732097     DOI: 10.1002/ana.20406

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  78 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

2.  Late onset Alexander's disease presenting as cerebellar ataxia associated with a novel mutation in the GFAP gene.

Authors:  Stephan Schmidt; Mike P Wattjes; Wanda M Gerding; Marjo van der Knaap
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

Review 3.  The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Authors:  Pietro Balbi; Silvana Salvini; Cira Fundarò; Giuseppe Frazzitta; Roberto Maestri; Dibo Mosah; Carla Uggetti; GianPietro Sechi
Journal:  J Neurol       Date:  2010-08-20       Impact factor: 4.849

Review 4.  Astrocytes in neurodegenerative disease.

Authors:  Hemali Phatnani; Tom Maniatis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-15       Impact factor: 10.005

Review 5.  Discrepancy between neuroimaging findings and clinical phenotype in Alexander disease.

Authors:  A Dinopoulos; J R Gorospe; J C Egelhoff; K M Cecil; P Nicolaidou; P Morehart; T DeGrauw
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

6.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

Review 7.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

8.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

9.  Can MR imaging diagnose adult-onset Alexander disease?

Authors:  L Farina; D Pareyson; L Minati; I Ceccherini; L Chiapparini; S Romano; P Gambaro; R Fancellu; M Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-03       Impact factor: 3.825

10.  An infantile case of Alexander disease unusual for its MRI features and a GFAP allele carrying both the p.Arg79His mutation and the p.Glu223Gln coding variant.

Authors:  Maria Teresa Dotti; Rosaria Buccoliero; Andrew Lee; J Raphael Gorospe; Daniel Flint; Paolo Galluzzi; Silvia Bianchi; Camilla D'Eramo; Sakkubai Naidu; Antonio Federico; Michael Brenner
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.